Zacks Initiates Coverage of CPIX With Outperform Recommendation

Zacks Investment Research has recently initiated coverage of Cumberland Pharmaceuticals Inc. (CPIX) with an “Outperform” recommendation, citing the company’s differentiated specialty pharmaceutical model, durable revenue opportunities and multiple long-term growth drivers.Cumberland Pharmaceuticals is a Nashville-based specialty pharma company focused on acquiring, developing and commercializing branded prescription products in hospital acute care, gastroenterology and oncology markets. The company’s strate ...